Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr. Kade Enters OTC Dermatology Space With Sirius Acquisition

Executive Summary

German firm Dr. Kade moves into the OTC dermatology category with an all-share acquisition of Sirius, which owns and markets the Siriderma Med range of OTC neurodermatitis and psoriasis treatments in Germany and will remain an independent company operating from Monheim am Rhein.

You may also be interested in...



Trust, Innovation And Growth – Three Priorities For The Global Self-Care Industry In 2021

The Global Self-Care Federation is looking to consolidate the shift towards self-care seen during the pandemic by promoting trust, innovation and growth in policy. An upcoming webinar hosted by the GSCF will also explore the theme of "Advancing Trust in the Self-Care Industry."

Sanofi Cracks Pill Pack Recycling Problem With UK TerraCycle Partnership

Sanofi Consumer Healthcare’s “Little Packs, Big Impact” partnership with TerraCycle will allow UK consumers to recycle Buscopan and Dulcolax pill packs by dropping them in dedicated containers in partnering pharmacies.

Greens Petition German Parliament For OTC COVID-19 Antibody Self Tests

Commercial COVID-19 antibody self-tests are back on the agenda in Europe, this time in Germany, where the Greens are calling for amendments to the country's medical devices regulations to allow tests to be sold OTC in pharmacies and incentives for industry to quickly scale up production. 

Topics

Related Companies

UsernamePublicRestriction

Register

LL1134025

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel